|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/06 | |||
| A61K 9/10 | |||
| A61K 9/16 | |||
| A61K 47/34 | |||
| A61K 38/31 |
| (11) | Number of the document | 2247282 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09705454.8 |
| Date of filing the European patent application | 2009-01-29 | |
| (97) | Date of publication of the European application | 2010-11-10 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/051026 |
| Date | 2009-01-29 |
| (87) | Number | WO 2009/095450 |
| Date | 2009-08-06 |
| (30) | Number | Date | Country code |
| 08150826 | 2008-01-30 | EP |
| (72) |
PETERSEN, Holger, DE
AHLHEIM, Markus, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS |
| SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS |